Bleakley Financial Group, LLC Seagen Inc. Transaction History

Bleakley Financial Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $87,520 - $98,785	-457 Reduced 5.98%	7,191 $1.53 Billion
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $10,507 - $11,550	56 Added 0.74%	7,648 $1.47 Billion
Q1 2023 May 12, 2023	BUY	$127.59 - $203.08 $81,912 - $130,377	642 Added 9.24%	7,592 $1.54 Billion
Q4 2022 Feb 07, 2023	BUY	$117.37 - $139.17 $815,721 - $967,231	6,950 New	6,950 $893 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Bleakley Financial Group, LLC with notifications on news.